The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Induction of Immunological Tolerance by Apoptotic Cells Requires Caspase-Dependent Oxidation of High-Mobility Group Box-1 Protein
Open accessAbstract
The mammalian immune system discriminates between modes of cell death; necrosis often results in inflammation and adaptive immunity, whereas apoptosis tends to be anti-inflammatory and promote immune tolerance. We have examined apoptosis for the features responsible for tolerance; specifically, we looked at the roles of caspases and mitochondria. Our results show that caspase activation targeted the mitochondria to produce reactive oxygen species (ROS), which were critical to tolerance induction by apoptotic cells. ROS oxidized the potential danger signal high-mobility group box-1 protein (HMGB1) released from dying cells and thereby neutralized its stimulatory activity. Apoptotic cells failed to induce tolerance and instead stimulated immune responses by scavenging or by mutating a mitochondrial caspase target protein when ROS activity was prohibited. Similarly, blocking sites of oxidation in HMGB1 prevented tolerance induction by apoptotic cells. These results suggest that caspase-orchestrated mitochondrial events determine the impact of apoptotic cells on the immune response.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“That said, it should be noted that biological activities of HMGB1 may flip from pro-inflammatory to anti-inflammatory depending on multiple variables including its oxidation state [917–923].”
From Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. (2018) · cites this paper as [921]
In the citing paper
“Potential immunogenic signals emanating from dying cells include proteins that appear at the surface of stressed and dying cells (such as calreticulin and heat shock proteins, HSPs), lipid moieties that flip from the inner plasma membrane leaflet to the outer leaflet (such as phosphatidylserine) 38,60, proteins that are released into the supernatant of cells (such as HMGB1) 51, as well as nucleic”
From Immunogenic and tolerogenic cell death (2009) · cites this paper as [51]
In the citing paper
“The inhibition of caspases affects the exposure of find-me signals 40, eat-me signals 40 (Box 4), and the secretion of DAMPs51 from dying cells, as well as the exposure of CRT on anthracyclin-treated cancer cells60.”
From Immunogenic and tolerogenic cell death (2009) · cites this paper as [51]
In the citing paper
“Thus, HMGB1 may act on the receptor for advanced glycated endproducts (RAGEs) and possibly the toll-like receptors (TLRs) including TLR2 and TLR4 51,52, although the latter are controversial 53.”
From Immunogenic and tolerogenic cell death (2009) · cites this paper as [51]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Release of chromatin protein HMGB1 by necrotic cells triggers inflammation
Scaffidi, P., Misteli, T., & Bianchi, M. E. (2002) · Nature · doi:10.1038/nature00858 · Cited by 4,221
The Danger Model: A Renewed Sense of Self
Matzinger, P. (2002) · Science · doi:10.1126/science.1071059 · Cited by 4,205
HMG-1 as a Late Mediator of Endotoxin Lethality in Mice
Wang, H., Bloom, O., Zhang, M., Vishnubhakat, J. M., Ombrellino, M., Che, J., Frazier, A., Yang, H., Ivanova, S., Borovikova, L. V., et al. (1999) · Science · doi:10.1126/science.285.5425.248 · Cited by 3,386
Yang, Y., Li, S., Yang, Q., Shi, Y., Zheng, M., Liu, Y., Chen, F., Song, G., Xu, H., Wan, T., et al. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000358696 · Cited by 3,263
Calreticulin exposure dictates the immunogenicity of cancer cell death
Obeid, M., Tesniere, A., Ghiringhelli, F., Fimia, G. M., Apetoh, L., Perfettini, J.-L., Castedo, M., Mignot, G., Panaretakis, T., Casares, N., et al. (2007) · Nature Medicine · doi:10.1038/nm1523 · Cited by 3,216
Fadok, V. A., Bratton, D. L., Konowal, A., Freed, P. W., Westcott, J. Y., & Henson, P. M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1112 · Cited by 3,166 · cited 4×
“Although these mediators can stimulate immunity, apoptotic cells can inhibit inflammatory and immunological responses driven by macrophages and DCs (Fadok et al., 1998).”
BackgroundInfluentialSteinman, R. M., Hawiger, D., & Nussenzweig, M. C. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141040 · Cited by 3,162
Apoptosis: controlled demolition at the cellular level
Taylor, R. C., Cullen, S. P., & Martin, S. J. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2312 · Cited by 2,708
Mitochondria, oxidative stress and cell death
Ott, M., Gogvadze, V. G., Orrenius, S., & Zhivotovsky, B. (2007) · APOPTOSIS · doi:10.1007/s10495-007-0756-2 · Cited by 2,020
Kamata, H., Honda, S.-I., Maeda, S., Chang, L., Hirata, H., & Karin, M. (2005) · Cell · doi:10.1016/j.cell.2004.12.041 · Cited by 1,792
Cited by
Sorted by citations
Items 301–400 of 626
Death in the fast lane: what's next for necroptosis?
Oberst, A. (2015) · FEBS Journal · doi:10.1111/febs.13520 · Cited by 47
Stepwise Release of Biologically Active HMGB1 during HSV-2 Infection
Borde, C., Barnay‐Verdier, S., Gaillard, C., Hocini, H., Maréchal, V., & Gozlan, J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016145 · Cited by 47
The Roles of High Mobility Group Box 1 in Cerebral Ischemic Injury
Gou, X., Ying, J., Yue, Y., Qiu, X., Hu, P., Qu, Y., Li, J., & Mu, D. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.600280 · Cited by 46
HMGB1-Mediated Activation of the Inflammatory-Reparative Response Following Myocardial Infarction
Foglio, E., Pellegrini, L., Russo, M. A., & Limana, F. (2022) · Cells · doi:10.3390/cells11020216 · Cited by 49
Inflammation and Fibrogenesis in MAFLD: Role of the Hepatic Immune System
Torre, P., Motta, B. M., Sciorio, R., Masarone, M., & Persico, M. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.781567 · Cited by 49
Recent Progress in Anti‐Tumor Nanodrugs Based on Tumor Microenvironment Redox Regulation
Yao, L., Zhu, X., Shan, Y., Zhang, L., Yao, J., & Xiong, H. (2024) · Small · doi:10.1002/smll.202310018 · Cited by 45
The alarmin functions of high-mobility group proteins
Yang, D., Tewary, P., de la Rosa, G., Wei, F., & Oppenheim, J. J. (2010) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2009.11.002 · Cited by 44
van Vliet, A. R., Martin, S., Garg, A. D., & Agostinis, P. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.03.010 · Cited by 44
Regulation of Acetylation in High Mobility Group Protein B1 Cytosol Translocation
Wang, Y., Wang, L., & Gong, Z. (2019) · DNA and Cell Biology · doi:10.1089/dna.2018.4592 · Cited by 46
Non-lethal outcomes of engaging regulated cell death pathways in cancer
Kalkavan, H., Rühl, S., Shaw, J. J. P., & Green, D. R. (2023) · Nature Cancer · doi:10.1038/s43018-023-00571-6 · Cited by 48
Self-citationA role for interleukin-33 in TH2-polarized intestinal inflammation?
Seidelin, J. B., Rogler, G., & Nielsen, O. H. (2011) · Mucosal Immunology · doi:10.1038/mi.2011.22 · Cited by 43
Vascular Remodelling and Mesenchymal Transition in Systemic Sclerosis
Nicolosi, P. A., Tombetti, E., Maugeri, N., Rovere, P. Q., Brunelli, S., & Manfredi, A. A. (2016) · Stem Cells International · doi:10.1155/2016/4636859 · Cited by 45
The inflammasome: an emerging therapeutic oncotarget for cancer prevention
Zhiyu, W., Wang, N., Wang, Q., Peng, C. Y., Zhang, J., Liu, P., Ou, A., Zhong, S., Cordero, M. D., & Lin, Y. (2016) · Oncotarget · doi:10.18632/oncotarget.9391 · Cited by 43
Autoantibody-dependent amplification of inflammation in SLE
Lou, H., Wójciak‐Stothard, B., Ruseva, M. M., Cook, H. T., Kelleher, P., Pickering, M. C., Mongkolsapaya, J., Screaton, G. R., & Xu, X. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-02928-6 · Cited by 43
Aaes, T. L., Verschuere, H., Kaczmarek, A., Heyndrickx, L., Wiernicki, B., Delrue, I., Craene, B. D., Taminau, J., Delvaeye, T., Bertrand, M. J. M., et al. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.1900072 · Cited by 44
Damage-Associated Molecular Patterns As Double-Edged Swords in Sepsis
Zhou, M., Aziz, M., & Wang, P. (2021) · Antioxidants and Redox Signaling · doi:10.1089/ars.2021.0008 · Cited by 44
Hu, J., He, J., Wang, Y., Yang, Z., Fang, K., Dong, Y., Chen, Y., Zhang, Y., Zhang, C., Wang, H., et al. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-003408 · Cited by 42
Metabolites and Immune Response in Tumor Microenvironments
Cortellino, S., & Longo, V. D. (2023) · Cancers · doi:10.3390/cancers15153898 · Cited by 43
Vogel, S., Börger, V., Peters, C., Förster, M., Liebfried, P., Metzger, K., Meisel, R., Däubener, W., Trapp, T., Fischer, J., et al. (2015) · Cell Death and Differentiation · doi:10.1038/cdd.2014.225 · Cited by 41
Until Death Do Us Part: Necrosis and Oxidation Promote the Tumor Microenvironment
Lotfi, R., Kaltenmeier, C., Lotze, M. T., & Bergmann, C. (2016) · Transfusion Medicine and Hemotherapy · doi:10.1159/000444941 · Cited by 42
Extracellular Vesicles and DAMPs in Cancer: A Mini-Review
Abu, N., Bakarurraini, N. A. A. R., & Nasir, S. N. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.740548 · Cited by 45
Immunomodulatory effect of locoregional therapy in the tumor microenvironment
Xie, L., & Meng, Z. (2023) · Molecular Therapy · doi:10.1016/j.ymthe.2023.01.017 · Cited by 41
TFAM is a novel mediator of immunogenic cancer cell death
Yang, M., Li, C., Zhu, S., Cao, L., Kroemer, G., Zeh, H. J., Tang, D., & Kang, R. (2018) · OncoImmunology · doi:10.1080/2162402x.2018.1431086 · Cited by 41
Zaki, A. M., El-Tanbouly, D. M., Abdelsalam, R. M., & Zaki, H. F. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.07.004 · Cited by 40
Moonlighting Proteins Are Important Players in Cancer Immunology
Adamo, A., Frusteri, C., Pallotta, M. T., Pirali, T., Sartoris, S., & Ugel, S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.613069 · Cited by 41
Metal-based immunogenic cell death inducers for cancer immunotherapy
Zou, J. X., Chang, M. R., Kuznetsov, N. A., Kee, J. X., Babak, M. V., & Ang, W. H. (2025) · Chemical Science · doi:10.1039/d4sc08495k · Cited by 42
Early stage blockade of the alarmin HMGB1 reduces cartilage destruction in experimental OA
Aulin, C., Lassacher, T. M., Palmblad, K., & Harris, H. E. (2020) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2020.01.003 · Cited by 38
Parodi, M., Pedrazzi, M., Cantoni, C., Averna, M., Patrone, M., Cavaletto, M., Spertino, S., Pende, D., Balsamo, M., Pietra, G., et al. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1052353 · Cited by 38
Peter, M. E. (2008) · Immunity · doi:10.1016/j.immuni.2008.06.006 · Cited by 38
Forcing the Antitumor Effects of HSPs Using a Modulated Electric Field
Minnaar, C., & Szász, A. (2022) · Cells · doi:10.3390/cells11111838 · Cited by 35
The Redox Protein High-Mobility Group Box 1 in Cell Death and Cancer
Chen, R., Zou, J., Kang, R., & Tang, D. (2023) · Antioxidants and Redox Signaling · doi:10.1089/ars.2023.0236 · Cited by 39
Ratikan, J. A., Micewicz, E. D., Xie, M. W., & Schaue, D. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.03.031 · Cited by 40
Nuclear Alarmin Cytokines in Inflammation
Jiang, L., Shao, Y., Tian, Y., Ouyang, C., & Wang, X. (2020) · Journal of Immunology Research · doi:10.1155/2020/7206451 · Cited by 38
The Role of HMGB1 in Rheumatic Diseases
Dong, Y., Ming, B., & Dong, L. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.815257 · Cited by 40
Essential role of high-mobility group box proteins in nucleic acid-mediated innate immune responses
Yanai, H., Ban, T., & Taniguchi, T. (2011) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2011.02433.x · Cited by 40
Mycobacterium tuberculosis infection induces non-apoptotic cell death of human dendritic cells
Ryan, R., O’Sullivan, M. P., & Keane, J. (2011) · BMC Microbiology · doi:10.1186/1471-2180-11-237 · Cited by 38
Ahn, J. G., Bae, Y., Shin, D., Nam, J., Kim, K. Y., & Kim, D. S. (2018) · Lara D. Veeken · doi:10.1093/rheumatology/key356 · Cited by 36
Kwak, M. S., Rhee, W. J., Lee, Y. J., Kim, H. S., Kim, Y. H., Kwon, M. K., & Shin, J. (2021) · Redox Biology · doi:10.1016/j.redox.2021.101858 · Cited by 37
HMGB1, angel or devil, in ischemic stroke
Gao, B., Wang, S., Li, J., Han, N., Ge, H., Zhang, G., & Chang, M. (2023) · Brain and Behavior · doi:10.1002/brb3.2987 · Cited by 32
Wirestam, L., Schierbeck, H., Skogh, T., Gunnarsson, I., Ottosson, L., Erlandsson-Harris, H., Wetterö, J., & Sjöwall, C. (2015) · Arthritis Research & Therapy · doi:10.1186/s13075-015-0856-2 · Cited by 37
Wakabayashi, A., Shimizu, M., Shinya, E., & Takahashi, H. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0665-z · Cited by 32
Zheng, S., Pan, Y., Wang, C., Liu, Y., Shi, M., & Ding, G. (2015) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2015.0067 · Cited by 34
High mobility group box 1 is increased in the sera of psoriatic patients with disease progression
Bergmann, C., Strohbuecker, L., Lotfi, R., Sucker, A., Joosten, I., Koenen, H. J. P. M., & Körber, A. (2016) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.13564 · Cited by 34
Regulation of efferocytosis by caspase-dependent apoptotic cell death in atherosclerosis
Tajbakhsh, A., Kovanen, P. T., Rezaee, M., Banach, M., Moallem, S. A., & Sahebkar, A. (2020) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2020.105684 · Cited by 35
Zhou, Y., Zhang, Y., Jiang, C., Chen, Y., Tong, F., Yang, X., Wang, Y., Xia, X., & Gao, H. (2023) · Small · doi:10.1002/smll.202300594 · Cited by 34
Sun, J., Guo, E., Yang, J., Yang, Y., Liu, S., Hu, J., Jiang, X., Dirsch, O., Dahmen, U., Dong, W., et al. (2017) · Liver Transplantation · doi:10.1002/lt.24733 · Cited by 34
Emerging role of high mobility group box 1 in ANCA-associated vasculitis
Wang, C., de Souza, A. W. S., Westra, J., Bijl, M., Chen, M., Zhao, M., & Kallenberg, C. G. M. (2015) · Autoimmunity Reviews · doi:10.1016/j.autrev.2015.07.010 · Cited by 32
Prix Fixe: Efferocytosis as a Four-Course Meal
Martinez, J. (2015) · Current topics in microbiology and immunology · doi:10.1007/82_2015_467 · Cited by 36
Zhu, L., Ren, L., Chen, Y., Fang, J., Ge, Z., & Li, X. (2015) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12577 · Cited by 33
Liu, D., Ling, Y., Dong, L. J., Zhang, J., Li, X., Chen, X., Huang, H., Deng, J., & Guo, Y. (2025) · Biomaterials · doi:10.1016/j.biomaterials.2025.123086 · Cited by 33
Reactive oxygen species responsive nanomotors for gene edited metabolic disruption and immunotherapy
Liu, Z., Luan, X., Lu, Q., Qin, S., Zeng, F., Li, Z., He, B., & Song, Y. (2025) · Nature Communications · doi:10.1038/s41467-025-59590-9 · Cited by 33
Williams, C. D., Koerner, M. R., Lampe, J. N., Farhood, A. I., & Jaeschke, H. (2011) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2011.10.006 · Cited by 32
HMGB1 Signaling-Mediated Tumor Immunity in Cancer Progress
Wen, J., & Zhang, X. (2023) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2810260 · Cited by 31
Shoda, L. K. M., Battista, C., Siler, S. Q., Pisetsky, D. S., Watkins, P. B., & Howell, B. A. (2017) · Gene Regulation and Systems Biology · doi:10.1177/1177625017696074 · Cited by 31
Li, J., Shi, J., Sun, Y., & Zheng, F. (2018) · DNA and Cell Biology · doi:10.1089/dna.2018.4444 · Cited by 31
Li, J.-H., Zhao, B., Zhu, X., Wang, L., Zou, H., Chen, S., Guo, H., Ruan, Y.-L., Zheng, F., Xiang, Y., et al. (2015) · American Journal of Transplantation · doi:10.1111/ajt.13275 · Cited by 31
Interleukin-33 in the human placenta
Topping, V. D., Romero, R. J., Than, N. G., Tarca, A. L., Xu, Z., Kim, S. Y., Wang, B., Yeo, L., Kim, C. J., Hassan, S. S., et al. (2012) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2012.735724 · Cited by 31
Transformable vesicles for cancer immunotherapy
Wang, S., Hu, X., Wei, W., & Ma, G. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113905 · Cited by 31
Bosurgi, L., Hughes, L. D., Rothlin, C. V., & Ghosh, S. (2017) · Immunological Reviews · doi:10.1111/imr.12585 · Cited by 32
Role of high-mobility group box 1 protein in inflammatory bowel disease
Hu, Z., Wang, X., Gong, L., Wu, G., Peng, X., & Tang, X. (2015) · Inflammation Research · doi:10.1007/s00011-015-0841-x · Cited by 30
HMGB1: a double-edged sword and therapeutic target in the female reproductive system
Ren, Y., Zhu, D., Han, X., Zhang, Q., Chen, B., Zhou, P., Wei, Z., Zhang, Z., Cao, Y., & Zou, H. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1238785 · Cited by 30
Lundbäck, P., Stridh, P., Klevenvall, L., Jenkins, R. E., Fischer, M., Sundberg, E., Andersson, U., Antoine, D. J., & Harris, H. E. (2014) · Antioxidants and Redox Signaling · doi:10.1089/ars.2014.6039 · Cited by 29
Lea, J. D., Clarke, J. I., McGuire, N., & Antoine, D. J. (2015) · Antioxidants and Redox Signaling · doi:10.1089/ars.2015.6406 · Cited by 29
SARS-CoV-2 Infection Induces HMGB1 Secretion Through Post-Translational Modification and PANoptosis
Kwak, M. S., Choi, S., Kim, J., Lee, H., Park, I. H., Oh, J., Ngoc, D. T., Cho, N., Nam, K. T., & Shin, J. (2023) · Immune Network · doi:10.4110/in.2023.23.e26 · Cited by 34
Matsumiya, M., Stylianou, E., Griffiths, K., Lang, Z., Meyer, J., Harris, S. A., Rowland, R., Minassian, A. M., Pathan, A. A., Fletcher, H. A., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067922 · Cited by 28
Gender Difference in Damage-Mediated Signaling Contributes to Pulmonary Arterial Hypertension
Rafikov, R., Nair, V., Sinari, S. A., Babu, H., Sullivan, J. C., Yuan, J. X. ‐., Desai, A. A., & Rafikova, O. (2019) · Antioxidants and Redox Signaling · doi:10.1089/ars.2018.7664 · Cited by 27
Histone deacetylase inhibitors in the generation of the anti‐tumour immune response
Leggatt, G. R., & Gabrielli, B. G. (2011) · Immunology and Cell Biology · doi:10.1038/icb.2011.94 · Cited by 26
Activated dendritic cells modulate proliferation and differentiation of human myoblasts
Ladislau, L., Portilho, D. M., Courau, T., Solares-Pérez, A., Négroni, E., Lainé, J., Klatzmann, D., Bonomo, A. C., Allenbach, Y., Benvéniste, O., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0426-z · Cited by 26
HMGB1 Mediates Paraquat-Induced Neuroinflammatory Responses via Activating RAGE Signaling Pathway
Huang, M., Guo, M., Wang, K., Wu, K., Li, Y., Tian, T., Wang, Y., Yan, W., Zhou, Z., & Yang, H. (2019) · Neurotoxicity Research · doi:10.1007/s12640-019-00148-1 · Cited by 27
Hemidesmus indicus induces immunogenic death in human colorectal cancer cells
Turrini, E., Catanzaro, E., Muraro, M. G., Governa, V., Trella, E., Mele, V., Calcabrini, C., Morroni, F., Sita, G., Hrelia, P., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.25325 · Cited by 29
Nebbioso, M., Lambìase, A., Armentano, M., Tucciarone, G., Bonfiglio, V. M. E., Plateroti, R., & Alisi, L. (2020) · Antioxidants · doi:10.3390/antiox9080666 · Cited by 26
Li, Y., Cao, Y., Ma, K., Ma, R., Zhang, M., Guo, Y., Song, H., Sun, N., Zhang, Z., & Yang, W. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202303568 · Cited by 25
Activation-Induced CD154 Expression Abrogates Tolerance Induced by Apoptotic Cells
Gurung, P., Kucaba, T. A., Ferguson, T. A., & Griffith, T. S. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901676 · Cited by 26
Self-citationEfferocytosis in dendritic cells: an overlooked immunoregulatory process
Ma, Y., Jiang, T., Zhu, X., Xu, Y., Wan, K., Zhang, T., & Xie, M. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1415573 · Cited by 24
News from the “5th international meeting on inflammatory bowel diseases” CAPRI 2010
Latella, G., Fiocchi, C., & Caprili, R. (2010) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2010.08.002 · Cited by 23
HMGB 1 genetic polymorphisms in oral squamous cell carcinoma and oral lichen planus patients
Šupić, G., Kozomara, R., Zeljić, K., Stanimirović, D., Magić, M., Šurbatović, M., Jović, N., & Magić, Z. (2015) · Oral Diseases · doi:10.1111/odi.12318 · Cited by 24
Mookerjee, A., Graciotti, M., & Kandalaft, L. E. (2018) · Bioimpacts · doi:10.15171/bi.2018.24 · Cited by 24
Orchestrated efforts on host network hijacking: Processes governing virus replication
Dai, X., Hakizimana, O., Zhang, X., Kaushik, A. C., & Zhang, J. (2020) · Virulence · doi:10.1080/21505594.2020.1726594 · Cited by 25
Lee, S., Hong, K. H., Park, H., Ha, J., Lee, S. E., Park, D. J., Jeong, S. D., Kim, S., Kim, D., Ahn, J., et al. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.07.004 · Cited by 25
Graphene-Induced Hyperthermia (GIHT) Combined With Radiotherapy Fosters Immunogenic Cell Death
Podolska, M. J., Shan, X., Janko, C., Boukherroub, R., Gaipl, U. S., Szunerits, S., Frey, B., & Munoz, L. E. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.664615 · Cited by 23
Zeng, Z., Fu, C., Sun, X., Niu, M., Ren, X., Tan, L., Wu, Q., Huang, Z., & Meng, X. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01699-w · Cited by 23
The Therapeutic Potential of Pyroptosis in Melanoma
Zaffaroni, N., & Beretta, G. L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021285 · Cited by 23
Hernández‐Pando, R., Barrios‐Payán, J., Mata‐Espinosa, D., Marquina‐Castillo, B., Hernández‐Ramírez, D. F., Botasso, O. A., & Bini, E. I. (2015) · PLoS ONE · doi:10.1371/journal.pone.0133200 · Cited by 23
Martin, A. J., McCarthy, D. P., Waltenbaugh, C. R., Goings, G. E., Luo, X., & Miller, S. D. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000802 · Cited by 23
Use of Anti-Cancer Drugs, Mitocans, to Enhance the Immune Responses against Tumors
Hahn, T., Polanczyk, M. J., Borodovsky, A., Ramanathapuram, L. V., Akporiaye, E. T., & Ralph, S. J. (2013) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201011314030010 · Cited by 22
Cellular mechanisms underlying the impairment of macrophage efferocytosis
Ma, Y., Kemp, S. S., Yang, X., Wu, M. H., & Yuan, S. Y. (2023) · Immunology Letters · doi:10.1016/j.imlet.2023.02.001 · Cited by 22
Mechanisms of Cell Death Induced by Optical Hyperthermia
Pérez-Hernández, M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813928-8.00008-9 · Cited by 22
The role of HMGB1 in inflammatory skin diseases
Satoh, T. K. (2022) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2022.07.005 · Cited by 22
The Expression of HMGB 1 on Microparticles from Jurkat and HL ‐60 Cells Undergoing Apoptosisin vitro
Spencer, D. M., Mobarrez, F., Wallén, H., & Pisetsky, D. S. (2014) · Scandinavian Journal of Immunology · doi:10.1111/sji.12191 · Cited by 22
Melis, M. H. M., Simpson, K., Dovedi, S. J., Welman, A., MacFarlane, M., Dive, C., Honeychurch, J., & Illidge, T. (2013) · Cell Death and Differentiation · doi:10.1038/cdd.2013.8 · Cited by 23
Emerging Therapeutic Targets in Oncologic Photodynamic Therapy
Manda, G., Hinescu, M. E., Neagoe, I. V., Ferreira, L. F. V., Boscencu, R., Vasos, P. R., Basaga, S. H., & Cuadrado, A. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190122163832 · Cited by 23
HMGB family proteins: Potential biomarkers and mechanistic factors in cardiovascular diseases
Zheng, X., Lu, J., Liu, J., Zhou, L., & He, Y. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115118 · Cited by 21
A microfluidic thyroid-liver platform to assess chemical safety in humans
Kuehnlenz, J. (2022) · ALTEX · doi:10.14573/altex.2108261 · Cited by 26
Pyroptosis: A Caspase-1-Dependent Programmed Cell Death and a Barrier to Infection
Labbè, K., & Saleh, M. (2011) · Springer eBooks · doi:10.1007/978-3-0348-0148-5_2 · Cited by 22
Dong, W., Yang, X., Li, X., Sheng, W., An, C., Zhang, J., Shi, X., & Dong, S. (2024) · Journal of the American Chemical Society · doi:10.1021/jacs.4c01413 · Cited by 22
The Emerging Role of the Receptor for Advanced Glycation End Products on Innate Immunity
Armando Rojas, R., Pérez-Castro, R., González, I., Delgado, F., Romero, J. A., & Rojas, I. (2013) · International Reviews of Immunology · doi:10.3109/08830185.2013.849702 · Cited by 19
HMGB1-Binding Heptamer Confers Anti-Inflammatory Effects in Primary Microglia Culture
Kim, I., & Lee, J.-K. (2013) · Experimental Neurobiology · doi:10.5607/en.2013.22.4.301 · Cited by 20
Anakoinosis: Correcting Aberrant Homeostasis of Cancer Tissue—Going Beyond Apoptosis Induction
Heudobler, D., Lüke, F., Vogelhuber, M., Klobuch, S., Pukrop, T., Herr, W., Gerner, C., Pantziarka, P., Ghibelli, L., & Reichle, A. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01408 · Cited by 20
Ladrech, S., Mathieu, M. N., Puel, J., & Lenoir, M. (2013) · European Journal of Neuroscience · doi:10.1111/ejn.12290 · Cited by 20
Immunogenicity of cancer cells: An overview
Singh, T., Bhattacharya, M., Mavi, A. K., Gulati, A., Rakesh, Sharma, N. K., Gaur, S., & Kumar, U. (2023) · Cellular Signalling · doi:10.1016/j.cellsig.2023.110952 · Cited by 20
Metadata
- Authors
- Kazama, H., Ricci, J.-E., Herndon, J. M., Hoppe, G., Green, D. R., & Ferguson, T. A.
- Affiliations
- Washington University in St. Louis (US)
- Université Côte d'Azur (FR)
- Cleveland Clinic (US)
- St. Jude Children's Research Hospital (US)
- Corresponding author
- Ferguson, Thomas A.
- Venue
- Immunity
- Publisher
- Elsevier BV
- Published
- 2008-07
- Volume
- 29
- Issue
- 1
- Pages
- 21-32
- ISSN
- 1074-7613 (ISSN-L)
- PMC
- PMC2704496
- OpenAlex
- W2084623259
- Cited by
- 627
- References
- 60
- Citations by year
- 2026: 24 · 2025: 23 · 2024: 33 · 2023: 35 · 2022: 24 · 2021: 38 · 2020: 32 · 2019: 26 · 2018: 33 · 2017: 31 · 2016: 20 · 2015: 44 · 2014: 47 · 2013: 43 · 2012: 34
- FWCI
- 19.04
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Immunity (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Research to Prevent Blindness (EY02687)
- National Institutes of Health (AI44848, EY02687, EY06765)
- National Eye Institute (EY 02687, P30EY002687, EY 015570, F32EY006765, EY06765, R01EY015570, R01EY006765)
- National Institute of Allergy and Infectious Diseases (AI44848, R01AI044828, R01AI040646)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Immunology and Microbiology › Immunology › Phagocytosis and Immune Regulation
- Keywords
- immune tolerance, apoptotic cells, caspases, HMGB1, high mobility group box 1 protein, reactive oxygen species, oxidative modification, damage-associated molecular patterns, necrosis, tolerance induction
- MeSH terms
- Animals, Dendritic Cells, HeLa Cells, Humans, Immune Tolerance, Mice, Inbred C57BL, Mitochondria, Oxidation-Reduction, Immunoblotting, Apoptosis, Reactive Oxygen Species, Caspases, HMGB1 Protein, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
